Keywords: Stroke; Antiepileptic drugs; Drug-drug interaction; Statins; Calcium channel blockers; Anticoagulants; AED; antiepileptic drug; EIAED; enzyme-inducer AED; NEIAED; non-EIAED; CCB; calcium-channel blocker; NOAC; non-vitamin K antagonist oral anticoagulant;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CCB; calcium channel blockers; ACEI; angiotensin converting enzyme inhibitor; CSC; Chinese single-pill combination; Hypertension; Primary; Antihypertensive drugs; Elderly; Prevalence;
Keywords: ACEi; angiotensin converting enzyme inhibitors; ARB; angiotensin receptor blockers; BCC; basal cell cancer; CCB; calcium channel blockers; CI; confidence intervals; NMSC; non-melanoma skin cancer; RR; relative risk; SCC; squamous cell cancer; SRR; summary
Keywords: ACC/AHA; American College of Cardiology/American Heart Association; ACE; angiotensin-converting enzyme; ANP; atrial natriuretic peptide; ARB; angiotensin II receptor blocker; BB; β-blocker; BMI; body mass index; BP; blood pressure; CCB; calcium channel b
Keywords: 3Ã-HSD; 3Ã-hydroxysteroid dehydrogenase-isomerase; ABPM; ambulatory blood pressure monitoring; Ang II; angiotensin II; ARB; angiotensin receptor blocker; AT1; angiotensin receptor type 1; AT2; angiotensin receptor type 2; ACE; angiotensin-converting enz
Keywords: BP; blood pressure; CV; cardiovascular; CAD; coronary artery disease; HF; heart failure; MI; myocardial infarction; CCB; calcium channel blocker; ARB; angiotensin receptor blocker; VALUE; Valsartan Antihypertensive Long-term Use Evaluation; ALLHAT; Antihy
Keywords: Aβ; amyloid beta; AD; Alzheimer's disease; BBB; blood brain barrier; CCB; calcium channel blocker; Chol; cholesterol; Cys; cysteine; DHPC; 1,2-dihexanoyl-sn-glycero-3-phosphocholine; DLPC; 1,2-dilauroyl-sn-glycero-3-phosphocholine; DMPC; 1,2-dimyristoyls
Keywords: ACC; American College of Cardiology; AHA; American Heart Association; CCB; calcium channel blocker; CVI; chronic venous insufficiency; EM; erythromelalgia; ISL; International Society of Lymphology; LDS; lipodermatosclerosis; MPFF; micronized purified flav
Keywords: Idiopathic pulmonary arterial hypertension; Cardiopulmonary exercise testing; Vasoreactivity testing; Calcium channel blockers; AT; anaerobic threshold; CCB; calcium channel blockers; CI; Cardiac index; CPET; cardiopulmonary exercise testing; DBP; diastol
Keywords: α-adrenergic blockade; Metyrosine; Paraganglioma; Phenoxybenzamine; Pheochromocytoma; AKI; acute kidney injury; CCB; calcium channel blocker; DM; diabetes mellitus; IQR; interquartile range; MET; metyrosine; MET + PBZ; metyrosine and phenoxybenzamine;
Keywords: CCB; coal combustion by-product; FGD; flue gas desulfurization; DFGD; dry flue gas desulfurization; DM; dry matter; ICP-MS; inductively coupled plasma-mass spectrometry; EPA; Environmental Protection Agency; LSD; least significant difference; NRC; Nationa
Keywords: antihypertensive therapy; cardiorenal syndrome; HFpEF; hypertensive heart disease; left ventricular hypertrophy; Pickering syndrome; ARAS; atheromatous renal artery stenosis; ACE; angiotensin-converting enzyme; ARB; angiotensin receptor blocker; BP; blood
Keywords: GL; Glass Fibres; KF; Kraft pulp Fibres; NSF; Nano Silica Fume; CCB; Cement Composite Board; WA; Water Absorption; MM; Moisture Movement; FS; Flexural Strength; SEM; Scanning Electron Microscopy; Cement composite; Cement board; Glass fibre; Nano Silica Fu
Keywords: catecholamine; heart surgery; post-operative atrial fibrillation; sympathetic activation; ACEi; angiotensin converting enzyme inhibitor; AF; atrial fibrillation; ARB; angiotensin receptor blocker; CCB; calcium channel blocker; COPD; chronic obstructive pu
Keywords: ARR; absolute risk reduction; CCB; calcium channel blocker; MD; mean difference; MeSH; medical subject headings; NNT; numbers needed to treat; MET; medical expulsive therapy; RCT; randomised controlled trial; RoB; risk of bias; RR; risk ratio; Ureteric st
Keywords: pulmonary hypertension; prematurity; bronchopulmonary dysplasia; echocardiography; pediatric pulmonary hypertension network; cardiac catheterization; ASDs; Atrial septal defects; AVT; Acute vasodilator testing; BPD; Bronchopulmonary dysplasia; BNP; Brain
Keywords: AHT; antihypertensive drug; CCB; calcium channel blocker; CI; confidence interval; HR; hazard ratio; NRS; non-randomised study; OR; odds ratio; PICOS; population, intervention, comparator, outcome, setting; RCT; randomised controlled trial; SIR; standardi
Keywords: AKT; protein kinase B; ARE; anti-oxidant response elements; CCB; colloidal Coomassie Blue; DIGE; difference gel electrophoresis; ERK; extracellular regulated kinase; Fasn; fatty acid synthase; Gck; glucokinase; Gpx/GPx; glutathione peroxidase; GS; glutath
Keywords: ACEI; angiotensin converting enzyme inhibitors; ARB; angiotensin receptor blocker; β-Blockers; beta adrenergic receptor blocker; BP; blood pressure; CCB; calcium channel blocker; CV; cardiovascular; DM; diabetes mellitus; HF; heart failure; HTN; hyperten
Keywords: ACEi; angiotensin-converting enzyme inhibitor; Aldo blocker; aldosterone antagonist; ARB; angiotensin receptor blocker; AZA; azathioprine; BMI; body mass index; BP; blood pressure; CCB; calcium channel blocker; CR; cardiac rehabilitation; ENaC; epithelial
Keywords: end-of-life; ethics; law; CCB; Consent and Capacity Board; CoP; Court of Protection; PVS; persistent vegetative state; TADA; Texas Advance Directives Act;
Keywords: AV; atrioventricular; CCB; Calcium channel blockers; Na+-K+-ATPase; sodium-potassium-exchanger; NCX-1; sodium-calcium-exchanger; PMCA1; plasma membrane Ca2Â +-ATPase isoform 1; RyR; ryanodine receptor isoform; SA; sinoatrial; SERCA2b; sarcoplasmic reticul
Keywords: AF; atrial fibrillation; BMI; body mass index; CCB; calcium channel blocker; CPRS; Computerized Patient Record System; CRF; cardiorespiratory fitness; CVD; cardiovascular disease; DM; diabetes mellitus; ETT; exercise tolerance test; HR; hazard ratio; HTN;
Keywords: Ram sperm; Cryopreservation; Proteome; ROS; Reactive oxygen species; ATP; Adenosine triphosphate; 2-DE; Two-dimensional gel electrophoresis; MALDI-TOF-TOF; Matrix-assisted laser desorption/ionization tandem time-of-flight mass spectrometry; HIRFL; Heavy I
Keywords: ACEI; Angiotensin converting enzyme inhibitors; ARB; Angiotensin receptor blocker; BP; Blood pressure; CCB; Calcium channel blocker; CHD; Coronary heart disease; CKD; Chronic kidney disease; CV; Cardiovascular; DRI; Direct renin inhibitor; HF; Heart failu
Keywords: Complainer emotions; Customer complaint behavior; CCB; Complaint management; Complexity theory; fsQCA;
Keywords: A. Engineering Mechanics; AAR; alkali-aggregate reaction; ASR; alkali-silica reaction; AIC; Akaike Information Criterion; BIC; Bayesian Information Criterion; BC; boundary condition; B; beam; CCB; concrete containment building; DOT; Department of Tran
Keywords: ACEI; Angiotensin converting enzyme inhibitors; ARB; Angiotensin receptor blocker; BP; Blood pressure; CCB; Calcium channel blocker; CHD; Coronary heart disease; CKD; Chronic kidney disease; CPGs; Clinical practice guidelines; CV; Cardiovascular; DHP-CCB;
Keywords: HTN; Hypertension or hypertensive; CVD; Cardiovascular disease; BP; Blood pressure; LV; Left ventricular or left ventricle; DM; Diabetes mellitus; LVM; Left ventricular mass; RWT; Relative wall thickness; CR; Concentric remodeling; LVH; Left ventricular h
Keywords: IIR; iron ion radiation; 2-DE; two-dimensional gel electrophoresis; MALDI-TOF-TOF; matrix-assisted laser desorption/ionization tandem time-of-flight mass spectrometry; HIRFL; Heavy Ion Research Facility in Lanzhou; CCB; Colloidal Coomassie Blue R 250; TBS
Keywords: extracorporeal membrane oxygenation; intervention; mortality; outcomes research; pediatric cardiology; Pediatric Health Information Systems Database; APAH-CHD; pulmonary arterial hypertension associated with congenital heart disease; CCB; calcium-channel
Keywords: CIR; carbon ion radiation; 2-DE; two-dimensional gel electrophoresis; MALDI-TOF-TOF; matrix-assisted laser desorption/ionization tandem time-of-flight mass spectrometry; HIRFL; Heavy Ion Research Facility in Lanzhou; CCB; Colloidal Coomassie Blue G 250; T
Keywords: ACVR2A; activin receptor II; BMPRII; bone morphogenetic protein-receptor type 2; CCB; calcium channel blocker; miRNA; microinterfering RNA; mPAP; mean pulmonary arterial pressure; NYHA; New York Heart Association; PAH; pulmonary arterial hypertension; PVR
Keywords: antihypertensive medications; cardiovascular disease; electronic health record; race; ACE; angiotensin-converting enzyme; AMI; acute myocardial infarction; BP; blood pressure; CCB; calcium-channel blocker; CI; confidence interval; CV; cardiovascular; CVD;
Keywords: ACEi; angiotensin-converting enzyme inhibitor; ADR; adverse drug reaction; CCB; calcium channel blocker; CKD; chronic kidney disease; CNI; calcineurin inhibitor; eGFR; estimated glomerular filtration rate; GFR; glomerular filtration rate; NSAID; nonsteroi
Keywords: CVD; cardio vascular disease; UAE; urinary albumin excretion; BMI; body mass index; ACE; angiotensin-converting enzyme; ARB; angiotensin II receptor blockers; ANOVA; analysis of variance; SBP; systolic blood pressure; CI; confidence interval; CCB; calcium
Keywords: AAD; antiarrhythmic drug; CAD; coronary artery disease; CCB; calcium channel blocker; DCM; dilated cardiomyopathy; ECG; electrocardiogram; ICM; ischemic cardiomyopathy; LV; left ventricular/ventricle; LVEDD; left ventricular end-diastolic dimension; LVEF;
Keywords: pediatrics; pulmonary hypertension; survival; APAH; associated pulmonary arterial hypertension; BNP; brain natriuretic peptide; CCB; calcium channel blocker; CHD; congenital heart disease; HPAH; hereditary pulmonary arterial hypertension; IPAH; idiopathic
Keywords: Proteome; Pubertal mice; Testis; Carbon ion radiation; HIR; heavy ions radiation; 2-DE; two-dimensional gel electrophoresis; MALDI-TOF-TOF; matrix-assisted laser desorption/ionization tandem time-of-flight mass spectrometry; HIRFL; heavy ion research faci
Keywords: 6MWD; 6-min walk distance; AHRQ; Agency for Healthcare Research and Quality; ARIES; Ambrisentan in Pulmonary Arterial Hypertension, Randomized Double-Blind, Placebo-Controlled, Multicenter, Efficacy Study; BNP; brain natriuretic peptide; CB; consensus-bas
Keywords: Anaphylaxis; antihypertensive medications; angiotensin-converting enzyme inhibitor; beta-blocker; risk factors; emergency department; ACE; Angiotensin-converting enzyme; CCB; Calcium channel blocker; ED; Emergency department; NIAID/FAAN; National Institut
Keywords: 2D-DIGE; two-dimensional differential gel electrophoresis; CCB; colloidal coomassie blue; ICy dyes; iodoacetyl cyanine dyes; MALDI-TOF MS; matrix assisted laser desorption ionization-time of flight mass spectrometry; mPR; membrane-associated progesterone
Keywords: AIR; Automated Image Registration; Amg; Amygdala; CC; Corpus Callosum; CCb; Body of the Corpus Callosum; CCg; Genu of the Corpus Callosum; CCs; Splenium of the Corpus Callosum; CN; Caudate Nucleus; CSF; Cerebrospinal Fluid; COSMOS; Calculation of Suscepti
PXR polymorphisms have impact on the clinical efficacy of clopidogrel in patients undergoing percutaneous coronary intervention
Keywords: ABCB1; ATP-binding cassette, sub-family B, member 1; ACEI; angiotensinconverting enzyme inhibitor; ADP; adenosine diphosphate; ARB; angiotensin receptor blocker; CCB; calcium channel blockers; CHD; Coronary Heart Disease; CLP; clopidogrel; CLPM; clopidogr
Reversible Cerebral Vasoconstriction Syndrome as an Unusual Complication of a Dural Arteriovenous Fistula treated with Onyx Embolization
Keywords: Endovascular; Headache; Onyx; Vasoconstriction; CCB; Calcium channel blocker; dAVF; Dural arteriovenous fistula; DMSO; Dimethyl sulfoxide; RCVS; Reversible cerebral vasoconstriction syndrome;
Preliminary analysis of the effect of Stevia (Stevia rebaudiana) in patients with chronic kidney disease (stage I to stage III)
Keywords: Stevia; Chronic kidney disease (CKD); Hypertension; Diabetes mellitus; Angiotensin-II receptor blocker (ARB); Ca2+ channel blocker (CCB); CKD; Chronic Kidney Disease; ARB; Angiotensin-II Receptor Blocker; CCB; Ca2+ Channel Blocker; STV; Stevia; PLC; Place
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy
Keywords: AMI; acute myocardial infarction; ACE-I/ARBs; Angiotensin Converting Enzyme (ACE) inhibitors/angiotensin receptor blockers; BMI; body mass index; CABG; coronary artery bypass grafting; COPD; chronic obstructive pulmonary disease; CRT; cardiac resynchroniz
Contribution of lectin-like oxidized low-density lipoprotein receptor-1 and LOX-1 modulating compounds to vascular diseases
Keywords: LOX-1; Endothelial dysfunction; Atherosclerosis; Pharmacological therapy: microRNAs; ACE; angiotensin converting enzyme; Ang II; Angiotensin II; AT1R; angiotensin II receptor type 1; CCB; calcium channel blocker; CRP; C-reactive protein; eNOS; endothelial
Serum proteome mapping of EGF transgenic mice reveal mechanistic biomarkers of lung cancer precursor lesions with clinical significance for human adenocarcinomas
Keywords: 2-DE; two-dimensional gel-electrophoresis; AC; adenocarcinoma; A2M; α-2-macroglobulin; AAH; atypical adenomatous hyperplasia; AAT; α-1-antitrypsin; ApoA1; apolipoprotein A-I; ApoA4; apolipoprotein A-IV; ApoC3; apolipoprotein C-III; ApoE; apolipoprotein
Frailty predicts major bleeding within 30 days in elderly patients with Acute Coronary Syndrome
Keywords: ACE Inhibitor; angiotensin-converting-enzyme inhibitor; ACS; Acute Coronary Syndrome; ARB; Angiotensin II Receptor Blocker; ASA; acetylsalicylic acid; BNP; brain natriuretic peptide; CABG; coronary artery bypass grafting; CCB; calcium channel blocker; CI;